@dean-wallace.bsky.social
Reposted
Practice changing plenary #ASH25‼️
Iron is hypothesized to feed infxn & IV iron often avoided in that setting.
>85k people hospitalized w/5 most common bacterial infxns, compared those who recvd IV iron to those who did not.
🩸greater hemoglobin increase
🩸lower mortality at 14 & 90 days
Iron is hypothesized to feed infxn & IV iron often avoided in that setting.
>85k people hospitalized w/5 most common bacterial infxns, compared those who recvd IV iron to those who did not.
🩸greater hemoglobin increase
🩸lower mortality at 14 & 90 days
December 6, 2025 at 6:46 PM
Practice changing plenary #ASH25‼️
Iron is hypothesized to feed infxn & IV iron often avoided in that setting.
>85k people hospitalized w/5 most common bacterial infxns, compared those who recvd IV iron to those who did not.
🩸greater hemoglobin increase
🩸lower mortality at 14 & 90 days
Iron is hypothesized to feed infxn & IV iron often avoided in that setting.
>85k people hospitalized w/5 most common bacterial infxns, compared those who recvd IV iron to those who did not.
🩸greater hemoglobin increase
🩸lower mortality at 14 & 90 days
Proud of Manchester’s paediatric participation in this game-changing trial published this week in @nejm.org
A golden dawn in renal rare disease
#C3G #IC-MPGN #pegcetacoplan #complement
www.nejm.org/doi/full/10....
A golden dawn in renal rare disease
#C3G #IC-MPGN #pegcetacoplan #complement
www.nejm.org/doi/full/10....
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN | NEJM
C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis
(MPGN) generally result in glomerular C3 deposition and irreversible kidney damage.
The efficacy and safety of ...
www.nejm.org
December 7, 2025 at 9:31 PM
Proud of Manchester’s paediatric participation in this game-changing trial published this week in @nejm.org
A golden dawn in renal rare disease
#C3G #IC-MPGN #pegcetacoplan #complement
www.nejm.org/doi/full/10....
A golden dawn in renal rare disease
#C3G #IC-MPGN #pegcetacoplan #complement
www.nejm.org/doi/full/10....